האגודה למלחמה בסרטן - במה - גיליון מס' 23 - מאי 2020

Open up more treatment possibilities for cancer patients with Foundation Medicine ® comprehensive genomic profiling

Extensively validated, FDA approved comprehensive genomic profiling to help guide personalized treatment decisions for solid tumors

FDA-approved broad comprehensive genomic profile

patients profiled >300k

biopharma partners >30

publications >300

FMI-1911-V2-3810